sustained viral response and hematological adverse events in children with chronic hepatitis c

نویسندگان

alessandra vigano department of pediatrics, luigi sacco hospital, university of milan, italy +2-39042253, [email protected]; department of pediatrics, luigi sacco hospital, university of milan, italy +2-39042253, [email protected]

valeria manfredini department of pediatrics, luigi sacco hospital, university of milan, italy

gian vincenzo zuccotti department of pediatrics, luigi sacco hospital, university of milan, italy

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Sustained Viral Response and Hematological Adverse Events in Children With Chronic Hepatitis C

Over the past decades, data from randomized controlled trials have confirmed the use of pegylated in-terferon alpha (peg-IFNα) plus ribavirin (RBV), as the mainstay of HCV therapy in adults (1). In children aged 3 years and older, the Food and Drug administration in the United States did not approve the use of this combination therapy until December 2008, and for children in Europe, approval fr...

متن کامل

Hematological Adverse events and Sustained Viral Response in Children Undergoing Therapy for Chronic Hepatitis C Infection

BACKGROUND Treatment of hepatitis C virus (HCV) infection with interferon (IFN) and ribavirin (RBV) is associated with adverse events, which may affect the patient's adherence to the treatment regimen and the treatment efficacy. OBJECTIVES The aim of this study was to assess the sustained viral response (SVR) and interdependence between the haematological characteristics (leukocyte count, pla...

متن کامل

Sustained Viral Response and Hematological Adverse Events During Chronic Hepatitis C Infection Treatment

Hepatitis C virus (HCV), as a causative agent of chronic liver disease, has infected approximately 175 million people (almost 3%) of the world's population; and 3 to 4 million new cases are added to this figure annually (1). Chronic HCV infection may progress to severe outcomes in the form of cirrhosis and hepatocellular carcinoma (HCC) (2). Currently, there is no effective HCV vaccine on the h...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
hepatitis monthly

جلد ۱۲، شماره ۳، صفحات ۲۱۱-۲۱۲

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023